If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 65   2004   NUMBER 4

CME Pretest 459

CME Posttest 588

Brainstorms

460 Anticonvulsants as Anxiolytics, Part 2: Pregabalin and Gabapentin as α2δ Ligands at Voltage-Gated Calcium Channels. Stephen M. Stahl
[PDF]

Editorial

462 Sex and Psychiatry in the Next 5 Years. Katherine L. Wisner
[PDF]

Original Articles

464 Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs. Jambur Ananth, Sharat Parameswaran, Sarath Gunatilake, Karl Burgoyne, and Taghrid Sidhom
[Abstract] [PDF]

471 Managing Atypical Antipsychotic-Associated Weight Gain: 12-Month Data on a Multimodal Weight Control Program. Matthew Menza, Betty Vreeland, Shula Minsky, Michael Gara, Diane Rigassio Radler, and Marie Sakowitz
[Abstract] [PDF]

478 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes. Richard H. Weisler, Amir H. Kalali, Terence A. Ketter, and the SPD417 Study Group
[Abstract] [PDF]

485 Speed of Response and Remission in Major Depressive Disorder With Acute Electroconvulsive Therapy (ECT): A Consortium for Research in ECT (CORE) Report. [CME] Mustafa M. Husain, A. John Rush, Max Fink, Rebecca Knapp, Georgios Petrides, Teresa Rummans, Melanie M. Biggs, Kevin O'Connor, Keith Rasmussen, Marc Litle, Wenle Zhao, Hilary J. Bernstein, Glenn Smith, Martina Mueller, Shawn M. McClintock, Samuel H. Bailine, and Charles H. Kellner
[Abstract] [PDF]

492 Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up. Thomas Frodl, Eva M. Meisenzahl, Thomas Zetzsche, Tom Höhne, Sandra Banac, Constanze Schorr, Markus Jäger, Gerda Leinsinger, Ronald Bottlender, Maximilian Reiser, and Hans-Jürgen Möller
[Abstract] [PDF]

500 The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update. Alexander L. Miller, Catherine S. Hall, Robert W. Buchanan, Peter F. Buckley, John A. Chiles, Robert R. Conley, M. Lynn Crismon, Larry Ereshefsky, Susan M. Essock, Molly Finnerty, Stephen R. Marder, Del D. Miller, Joseph P. McEvoy, A. John Rush, Sy A. Saeed, Nina R. Schooler, Steven P. Shon, Scott Stroup, and Bernardo Tarin-Godoy
[Abstract] [PDF]

509 Suicide Attempts and Ideation in Patients With Bipolar I Disorder. Andrea Fagiolini, David J. Kupfer, Paola Rucci, John A. Scott, Danielle M. Novick, and Ellen Frank
[Abstract] [PDF]

515 Effect of Reboxetine on Major Depressive Disorder in Breast Cancer Patients: An Open-Label Study. Luigi Grassi, Bruno Biancosino, Luciana Marmai, and Roberto Righi
[Abstract] [PDF]

521 The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates? Maurizio Fava, Craig H. Mallinckrodt, Michael J. Detke, John G. Watkin, and Madelaine M. Wohlreich
[Abstract] [PDF]

531 Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone. Henry A. Nasrallah, Inge Duchesne, Angelika Mehnert, Carmela Janagap, and Mariëlle Eerdekens
[Abstract] [PDF]

537 Lack of Effect of Intravenous Immunoglobulins on Tics: A Double-Blind Placebo-Controlled Study. Pieter J. Hoekstra, Ruud B. Minderaa, and Cees G. M. Kallenberg
[Abstract] [PDF]

543 Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder. George I. Papakostas, Timothy J. Petersen, Dan V. Iosifescu, Paul Summergrad, Katherine G. Sklarsky, Jonathan E. Alpert, Andrew A. Nierenberg, and Maurizio Fava
[Abstract] [PDF]

547 Hyperlipidemia in Persons Using Antipsychotic Medication: A General Population-Based Birth Cohort Study. Kaisa Saari, Hannu Koponen, Jaana Laitinen, Jari Jokelainen, Liisa Lauren, Matti Isohanni, and Sari Lindeman
[Abstract] [PDF]

551 Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia. [CME] Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Jeffrey A. Lieberman, Leslie Citrome, Brian Sheitman, Joseph P. McEvoy, Thomas B. Cooper, and Miranda Chakos
[Abstract] [PDF]

557 Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics. Natalie Alméras, Jean-Pierre Després, Julie Villeneuve, Marie-France Demers, Marc-André Roy, Camille Cadrin, Jean-Pierre Mottard, and Roch-Hugo Bouchard
[Abstract] [PDF]

565 Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial. Alexander Bystritsky, Deborah L. Ackerman, Richard M. Rosen, Tanya Vapnik, Eda Gorbis, Karron M. Maidment, and Sanjaya Saxena
[Abstract] [PDF]

Academic Highlights

569 International Consensus Group on Bipolar I Depression Treatment Guidelines.
[PDF]

Letters To the Editor

580 Lack of Association Between Plasma Apolipoprotein E and Suicide Attempts. Enrique Baca-Garcia, Carmen Diaz-Sastre, Eloy García-Resa, Antonio Ceverino, Antonio Ramirez, Jeronimo Saiz-Ruiz, and Jose de Leon
[PDF]

581 Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects. Gregory M. Asnis, Richard De La Garza II, Andrew H. Miller, and Charles L. Raison
[PDF]

  • Reply by Michael R. Kraus and Arne Schäfer

582 Olanzapine May Cause Delirium in Geriatric Patients. Steven Samuels and Margaret Fang
[PDF]

583 A Case of Tardive Dystonia Successfully Managed With Quetiapine. Yukiya Sasaki, Ichiro Kusumi, and Tsukasa Koyama
[PDF]

584 A Rose by Any Other Name. Bruce Sutor
[PDF]

Book Reviews 585

Worldview of psychiatry 586

NOW @ Psychiatrist.com 590

Information for authors

see www.psychiatrist.com/author.htm